Naloxone is a life-saving medication that can reverse an overdose that is caused by an opioid drug (i.e. prescription pain medication or heroin). Naloxone may be obtained at a pharmacy using the statewide standing order (https://www.health.pa.gov/topics/Documents/Opioids/General Public Standing Order.pdf) signed by Secretary of Health, Dr. Rachel Levine. Naloxone may be covered by insurance and consumers are encouraged to check with their insurers to understand their insurance coverage for naloxone. Individuals covered by Medicaid can obtain naloxone without a copay. A video demonstrating how to administer nasal spray naloxone may be found here - https://www.youtube.com/watch?v=v26cDao4AcI&feature=youtu.be

More information about how naloxone works as a medication and frequently asked questions about obtaining and using naloxone may be found on the Department of Health’s Naloxone webpage (https://www.health.pa.gov/topics/disease/Opioids/Pages/Naloxone.aspx)

*This is a comprehensive listing of all pharmacies registered with the Department of State in Pennsylvania and does not guarantee that the pharmacy listed will have naloxone in stock.

This dataset reports county numbers of intakes by individuals seeking treatment from hotline staff since the inception of Pennsylvania’s Get Help Now Hotline, text line, and chat line in November 2016.
When a field is blank the information is not available; these data were not collected at the time of the phone call.

Mean Length of Stay (LOS) for all Pennsylvania general acute care hospital stays for newborns, categorized by the presence or absence of Neonatal Abstinence Syndrome (NAS).
Neonatal Abstinence Syndrome, or neonatal drug withdrawal, is an array of problems that develops shortly after birth in newborns who were exposed to addictive drugs, most often opioids, while in the mother’s womb. Withdrawal signs develop because these newborns are no longer exposed to the drug for which they have become physically dependent.
This analysis is restricted to newborns with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals. Additionally, hospital stays with rehabilitation revenue codes and hospital stays that ended in a transfer or mortality were excluded.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.
PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

This dataset contains the total counts of PA Department of Human Services (DHS) Medical Assistance (MA) individuals diagnosed with Opioid Use Disorder (OUD) or OUD Poisoning. Also included are individuals receiving MAT (Medication assisted treatment - the use of medications in combination with counseling and behavioral therapies for the treatment of substance use disorders.) NOT diagnosed in the same period. Limited to the Newly Eligible (Under the Medical Assistance Expansion Program. Find more information here: http://www.dhs.pa.gov/cs/groups/webcontent/documents/document/c_257436.pdf) segment of DHS population. Internally defined as DHS Category of Assistance = MG (Modified Adjusted Gross Income - MAGI) MG and Program Status = 91 (Newly Eligible). Counts are reported by Pennsylvania case county and covers calendar years 2015 -2018.

Percent of Pennsylvania newborn hospital stays, categorized by the presence or absence of Neonatal Abstinence Syndrome (NAS), with Medicaid as the Anticipated Primary Payer.
Neonatal Abstinence Syndrome, or neonatal drug withdrawal, is an array of problems that develops shortly after birth in newborns who were exposed to addictive drugs, most often opioids, while in the mother’s womb. Withdrawal signs develop because these newborns are no longer exposed to the drug for which they have become physically dependent.
This analysis is restricted to newborns with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.
PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

This data set includes the estimated number of individuals in Pennsylvania with Drug Use Disorder, which is an approximation for Opioid Use Disorder prevalence. The estimates are developed by applying mortality weights derived from the CDC’s National Center for Health Statistics to statewide illicit drug use estimates from the National Survey on Drug Use and Health (NSDUH, sponsored by the Substance Abuse and Mental Health Services Administration).

Percent of hospitalizations for opioid overdose, categorized by a principal diagnosis of heroin overdose or opioid pain medication overdose, with specified anticipated primary payer as listed in the hospital record.

This analysis is restricted to Pennsylvania residents age 15 and older who were hospitalized in Pennsylvania general acute care hospitals.

This interactive map depicts the amount of Fentanyl, in kilograms, seized by the Pennsylvania State Police quarterly, by county. Use the drop-down menus to select quarter and year to see the amount of Fentanyl seized by the Pennsylvania State Police in each county. Care should be taken regarding inferences made about the location in which Fentanyl is seized as drugs can be transient and therefore seized in areas other than their origination or destination. The Fentanyl seizures reflected on this map may not include all active investigations by the Pennsylvania State Police.

Percent of Pennsylvania delivery hospital stays, categorized by the presence or absence of opioid use, that had at least one readmission within 365 of being discharged.

Opioid use, or opioid use disorder, is a diagnosis indicating opioid dependence, abuse, or use. Some opioid drugs may be prescribed as part of medication-assisted treatment to relieve withdrawal symptoms and psychological cravings often associated with opioid use disorders. Opioid use during pregnancy can lead to Neonatal Abstinence Syndrome (NAS) for newborns.

This analysis is restricted to delivery hospital stays with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.

PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

This dataset contains summary information by county on Incidents involving Drug and Alcohol reported use in Schools.
School categories are Public School, Charter, Intermediate, Vo-Tech, Non-Public and other.
The data count fields are suppressed when less than 11.
The data and more information is also published and searchable online on the https://www.education.pa.gov/Schools/safeschools/Pages/default.aspx website under School Safety.
Here are the infraction codes and definitions that are utilized within this report as found within appendix Z of the PIMS manual:
http://www.education.pa.gov/Documents/Teachers-Administrators/PIMS/PIMS%20Manuals/2017-2018%20PIMS%20Manual%20Vol%202.pdf